Related Experiment Video
Updated: May 17, 2025
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Severe Pneumonia
Patrick R Ching1, Laura L Pedersen2
1Division of Infectious Diseases, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, 1000 East Marshall Street, Suite 107, Richmond, VA 23298, USA; Healthcare Infection Prevention Program, Virginia Commonwealth University Health, Richmond, VA, USA.
Severe pneumonia, a global health threat, necessitates intensive care due to diverse microbial causes. Early antimicrobial and nonantimicrobial treatments are key to improving patient survival and outcomes.
Area of Science:
- Medicine
- Infectious Diseases
- Critical Care Medicine
Background:
- Severe pneumonia is a significant global cause of death and illness.
- It is a complex infectious disease caused by bacteria, viruses, and fungi, often requiring intensive care.
- Effective management involves prompt antimicrobial therapy and supportive nonantimicrobial interventions.
Purpose of the Study:
- To provide a comprehensive review of the latest research on severe pneumonia.
- To cover epidemiology, microbiology, diagnostic approaches, and treatment strategies.
- To highlight recent advancements in managing this critical condition.
Main Methods:
- Literature review of recent studies and clinical data.
- Synthesis of epidemiological trends and etiological factors.
- Analysis of current diagnostic criteria and therapeutic guidelines.
Main Results:
- Severe pneumonia remains a major global health challenge with high mortality rates.
- A diverse range of microorganisms contribute to its pathogenesis.
- Combined early antimicrobial and nonantimicrobial interventions demonstrate improved patient outcomes.
Conclusions:
- Prompt diagnosis and multifaceted treatment are crucial for managing severe pneumonia.
- Continued research into epidemiology, microbiology, and novel therapies is essential.
- Optimizing patient care through evidence-based strategies can reduce morbidity and mortality.
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:26Pneumothorax-I
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....